Trial intelligence / Profile preview

Antibiotic prophylaxis and mechanical bowel preparation before elective right hemicolectomy

2019-002002-43Phase 4Terminated

Sponsor
IIS Aragón
Start
Oct 2019
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of erythromycin, neomycin, sodium picosulfate, magnesium oxide and citric acid in surgical site infection (SSI) (3 arms), sponsored by IIS Aragón. Primary endpoints: Temperature and Surgical site infection incidence. Started Oct 2019; status: terminated.

02

Drugs

erythromycinneomycinsodium picosulfatemagnesium oxidecitric acid
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on 2019-002002-43.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-002002-43.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call